Article citationsMore>>

Branch, D.W., Peaceman, A.M., Druzin, M., et al. (2000) Multicenter, placebo-controlled pilot study of intravenous immune globulin treatment of antiphospholipid syndrome during pregnancy. The Pregnancy Loss Study Group. American Journal of Obstetrics & Gynecology, 122-182. doi:10.1016/S0 002-9378(00)70500-X

has been cited by the following article:

• TITLE: Antiphospholipid antibody syndrome and pregnancy

  AUTHORS: S. Errarhay, N. Hmidani, S. Mahmoud, L. Labib, H. Saadi, M. Hrandou, C. Bouchikhi, A. Banani

  KEYWORDS: Anti-Phospholipid Antibody Syndrome; Pregnancy; Treatment; Prognosis

  JOURNAL NAME: Open Journal of Obstetrics and Gynecology, Vol.3 No.4, May 22, 2013

  ABSTRACT: Recurrent foetal loss in early and late stages of pregnancy is a common problem of women affected by anti-phospholipid antibody syndrome. The therapeutic scheme consisting of associating aspirin and heparin has shown an improvement of the prognosis for the next pregnancies. We report 3 cases of anti-phospholipid antibody syndrome and pregnancy, and we underline the clinical, therapeutic and prognosis features of this syndrome.